We ain’t stupid

We’re not exactly sure what a PR person does but in our wacky world but they are doing it very badly. When the bruhaha over the high out of pocket of insulin began the insulin companies missed an opportunity to explain themselves, allowed the narrative to be determined for them and as we noted it had no choice but to play defense. Not sure exactly what they were thinking but given the topic – high prescription drug prices – combined with the fact that real people died the insulin companies didn’t stand a chance.

We have to give Lilly some . . .

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.